Login

Gianmarco Orgnoni, COO of Vection Technologies (ASX: VR1), joins ASX Investor Channel to discuss company developments and strategies. 00:10:00

Share On Facebook Share On Twitter

Gianmarco Biagi is the CEO of Vection Technologies.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
What methods can we employ to responsibly provide food for an expanding global populace?|Johan Westman, CEO ,AAK
00:10:00
StrikePoint Gold Gears Up for Drilling at Hercules Project in Nevada|Michael G. Allen,CEO,StrikePoint Gold Inc
00:10:00
CD International Enterprises Completes Acquisition of EM Resource Enterprises Inc.
00:10:00
Strategic Metals: Capitalizing on Yukon's Mining Potential
00:10:00
The Empresa Nacional de Telecomunicaciones (ENTEL S.A.) remembers during the 57th anniversary of its creation. | Antonio Buc, CEO, Empresa Nacional de Telecomunicaciones SAENTEL:SGO
00:10:00
Tailored Financial Advice: Matching Client Needs with Expertise
00:10:00
solo capitalists are winning|Itamar Novick,Founder,Recursive Ventures
00:10:00
Milestones Ahead for Lithium Extraction from Play Deposit
00:10:00
Driving Innovation in Mining Exploration through BHP Explore
00:10:00
Fabián Gosselin, CEO of Alsea, Shares His Management Secrets | Fabián Gosselin, CEO , Alsea SAB de CV.
00:10:00
The Evolution of the American Welfare State: Intellectual Foundations and Modern Implications|William Voegeli
00:10:00
ChartRight Air Group Expands to Lake Simcoe Regional Airport

© 2017 - Neuhu+